www.astellas.com
Open in
urlscan Pro
2606:4700::6812:1ae0
Public Scan
Submitted URL: http://astellas.com/
Effective URL: https://www.astellas.com/en/
Submission: On November 12 via manual from US — Scanned from DE
Effective URL: https://www.astellas.com/en/
Submission: On November 12 via manual from US — Scanned from DE
Form analysis 1 forms found in the DOM
GET /en/search
<form action="/en/search" method="get" id="views-exposed-form-acquia-search-acquia-search-page" accept-charset="UTF-8">
<div class="form--inline clearfix">
<div class="js-form-item form-item js-form-type-search-api-autocomplete form-type-search-api-autocomplete js-form-item-keys form-item-keys form-no-label">
<input placeholder="Search" aria-label="Search" data-drupal-selector="edit-keys" data-search-api-autocomplete-search="acquia_search" class="form-autocomplete form-text ui-autocomplete-input"
data-autocomplete-path="/en/search_api_autocomplete/acquia_search?display=acquia_search_page&&filter=keys" type="text" id="edit-keys" name="keys" value="" size="30" maxlength="128" data-once="autocomplete search-api-autocomplete"
autocomplete="off">
</div>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"> <button data-drupal-selector="edit-submit-acquia-search" type="submit" id="edit-submit-acquia-search" value="Search"
class="button js-form-submit form-submit" aria-label="Search"><span class="search-button-text">Search</span></button>
</div>
</div>
</form>Text Content
Search
Search
menu
* Top MenuAbout
Corporate Strategic Plan 2021
Corporate Strategic Plan 2021 (CSP2021) maps the next five years of our
journey.
Read More
From the CEOPhilosophy
* Astellas Charter of Corporate Conduct, Group Code of Conduct
VISIONAt a Glance
* Subsidiaries & Locations
* Our Business
* Main Products
* History
* Management
Board of DirectorsGlobal Management StructureCorporate Governance Materials
* Risk Management
Policies & Position StatementsEthics & Compliance
* Structure to Promote Ethics and Compliance
* Primary Areas of Focus
* Elements of Astellas’ Global Ethics & Compliance Program
* Enhancing and Sustaining an Ethical and Compliant Culture at Astellas
* Astellas awarded Compliance Leader Verification™
* Astellas Charter of Corporate Conduct, Group Code of Conduct
* Subsidiaries & Locations
* Our Business
* Main Products
* History
* Management
* Risk Management
* Structure to Promote Ethics and Compliance
* Primary Areas of Focus
* Elements of Astellas’ Global Ethics & Compliance Program
* Enhancing and Sustaining an Ethical and Compliant Culture at Astellas
* Astellas awarded Compliance Leader Verification™
* Top MenuInnovation
Innovation
We pursue cutting-edge science to continuously provide innovative treatment
options.
Read More
R＆D Strategy
* Drug Research
* Major Pipeline
* Clinical Trials
* Investigator Sponsored Research
* Grants for Education and General Research
* Grants to HCOs to Support HCP Attendance at Congresses
Areas of Interest
* Primary Focus
* Genetic Regulation
* Immuno-Oncology
* Blindness & Regeneration
* Targeted Protein Degradation
* Primary Focus Candidates
* Immune Homeostasis
* Exploratory Research
* Bispecific Immune Cell Engager
* Engineered Phage Therapy
* Direct Reprogramming
* Innate Immune Regulation
* Circadian Rhythm Regulation
* Cell Therapy
Digital Transformation
* DX Initiatives Throughout the Value Chain
* Data, Information and Advanced Analytics
New Healthcare Solutions Beyond Medicine (Rx+®)
* Leading Programs
* Investigational Near-Infrared Fluorescence Imaging Agent
* Clinically Relevant Holistic Solutions Mobile Healthcare Application
* New Digital Solution for Heart Failure Patients on the Horizon
Open Innovation in Drug Discovery Research
* Our Philosophy of Open Innovation
* Our Labs
* SakuLab-Tsukuba
* TME iLab
* SakuLab-Cambridge MA
Partnering
* Drug Research
* Major Pipeline
* Clinical Trials
* Investigator Sponsored Research
* Grants for Education and General Research
* Primary Focus
* Primary Focus Candidates
* Exploratory Research
* Cell Therapy
* DX Initiatives Throughout the Value Chain
* Data, Information and Advanced Analytics
* Leading Programs
* Our Philosophy of Open Innovation
* Our Labs
* Grants to HCOs to Support HCP Attendance at Congresses
* Genetic Regulation
* Immuno-Oncology
* Blindness & Regeneration
* Targeted Protein Degradation
* Immune Homeostasis
* Bispecific Immune Cell Engager
* Engineered Phage Therapy
* Direct Reprogramming
* Innate Immune Regulation
* Circadian Rhythm Regulation
* Investigational Near-Infrared Fluorescence Imaging Agent
* Clinically Relevant Holistic Solutions Mobile Healthcare Application
* New Digital Solution for Heart Failure Patients on the Horizon
* SakuLab-Tsukuba
* TME iLab
* SakuLab-Cambridge MA
* Top MenuInvestors
Investor Relations
You can access to IR related information including IR Library, Financial
Information, Corporate Strategic Plan.
Read More
Topics
* Corporate Strategic Plan 2021
* Integrated Report
* Archives
* Astellas’ ESG Initiatives
* Action to Implement Management that is Conscious of Cost of Capital and
Stock Price
Financial InformationIR Library
* Business Results
* Overview of R&D Pipeline
* IR Meetings
* Consolidated Financial Statements and Footnotes
* Corporate Governance Materials
IR CalendarStock & Rating Information
* Shareholders Meeting
* Shareholder Return
* Current Share Status
* Chart
* Issuer Rating
* Analyst Coverage
Cautionary StatementIntroducing Astellas to Individual Investors
* Corporate Strategic Plan 2021
* Integrated Report
* Astellas’ ESG Initiatives
* Action to Implement Management that is Conscious of Cost of Capital and
Stock Price
* Business Results
* Overview of R&D Pipeline
* IR Meetings
* Consolidated Financial Statements and Footnotes
* Corporate Governance Materials
* Shareholders Meeting
* Shareholder Return
* Current Share Status
* Chart
* Issuer Rating
* Analyst Coverage
* Archives
* Top MenuSustainability
Sustainability Direction
We have set Med-term Priorities, Initiatives, and Our Commitments by FY2025
as for Two pillars and Environmental Sustainability.
Read More
Message from CEOSustainability Approach
* Sustainability Governance
* Key Issues and Materiality
* Sustainability Direction
* Sustainability Direction Performance Indicators (SDPIs)
* ISO26000
* Astellas’ SDG Initiatives
* United Nations Global Compact
* Stakeholder Communications
* Awards & Recognition
Access to Health
* Access to Health of Astellas
* Access to Medicines
* Initiatives in Tanzania
* Healthcare Systems Strengthening
* Program in Mexico
* Program in Dominican Republic
* Program in Peru
* Program in Malaysia
* Development for Schistosomiasis
* Research Activity on Malaria
* Research Activities on NTDs
* Astellas Healthcare E-city
* GHIT Fund
* Patient Support Activity
* Working together to bring “medical-eco” activities to drug discovery in
Japan
* Commitment to healthcare for local communities
* Activities of "Project Commune" in FY 2023
* Activities of "Project Commune" in FY 2024
* Medical Science Advancement
* Astellas Global Health Foundation
* Access to Medicine Index Report
Environment
* Environment Initiatives
* EHS Management
* ISO certification status of Astellas production sites
* Environmental Action Plan and Compliance
* Climate Change Measures
* Scope 3 emissions (past 3 years)
* Disclosure based on TCFD
* Energy Consumption
* Sustainable Biodiversity
* Biodiversity and Astellas An Enlarged Version
* The Biodiversity Burden Index and Revenue
* Resource Recycling
* Preventing Pollution
* Further information on PRTR system
* Environmental Impact of Products and Countermeasures
* Archive (EHS Report)
* Environmental Accounting
* Environment-related Investments and Expenses
* Reporting coverage, methods
Astellas and Society
* Our People
* HR Vision, Talent and Organization Management
* Engagement and Diversity, Equity & Inclusion
* A living wage
* Occupational Health & Safety
* Promoting Health Management
* Major Activities and Programs (Japan)
* Sustainability in Business Practice
* Sustainable Procurement Initiatives
* Research Initiatives
* Clinical Development Initiatives
* Technological Development and Production Initiatives
* Distribution and Sales Initiatives
* Respect for Human Rights
* Community Engagement
* Flying Star Fund
* Employee Contributions to the Local Community
GovernanceESG Data
* ESG Data Environment
* ESG Data Social
* ESG Data Governance
* Sustainability Governance
* Key Issues and Materiality
* Sustainability Direction
* Sustainability Direction Performance Indicators (SDPIs)
* ISO26000
* Astellas’ SDG Initiatives
* United Nations Global Compact
* Stakeholder Communications
* Awards & Recognition
* Access to Health of Astellas
* Access to Medicines
* Healthcare Systems Strengthening
* Development for Schistosomiasis
* Research Activity on Malaria
* Research Activities on NTDs
* Astellas Healthcare E-city
* GHIT Fund
* Patient Support Activity
* Working together to bring “medical-eco” activities to drug discovery in
Japan
* Commitment to healthcare for local communities
* Medical Science Advancement
* Astellas Global Health Foundation
* Access to Medicine Index Report
* Environment Initiatives
* EHS Management
* Environmental Action Plan and Compliance
* Climate Change Measures
* Disclosure based on TCFD
* Energy Consumption
* Sustainable Biodiversity
* Resource Recycling
* Preventing Pollution
* Environmental Impact of Products and Countermeasures
* Archive (EHS Report)
* Environmental Accounting
* Reporting coverage, methods
* Our People
* Sustainability in Business Practice
* Respect for Human Rights
* Community Engagement
* ESG Data Environment
* ESG Data Social
* ESG Data Governance
* Initiatives in Tanzania
* Program in Mexico
* Program in Dominican Republic
* Program in Peru
* Program in Malaysia
* Activities of "Project Commune" in FY 2023
* Activities of "Project Commune" in FY 2024
* ISO certification status of Astellas production sites
* Scope 3 emissions (past 3 years)
* Biodiversity and Astellas An Enlarged Version
* The Biodiversity Burden Index and Revenue
* Further information on PRTR system
* Environment-related Investments and Expenses
* HR Vision, Talent and Organization Management
* Engagement and Diversity, Equity & Inclusion
* A living wage
* Occupational Health & Safety
* Promoting Health Management
* Major Activities and Programs (Japan)
* Sustainable Procurement Initiatives
* Research Initiatives
* Clinical Development Initiatives
* Technological Development and Production Initiatives
* Distribution and Sales Initiatives
* Flying Star Fund
* Employee Contributions to the Local Community
* Top MenuNews
News Room
Check the latest news and our people's stories.
Read More
ALL NewsOUR STORIESMedia Library
STAKEHOLDERS MENU
* Partnering
* Why Partner with Astellas
* Partnering Teams
* Testimonies from our Partners
* Registration Form
* Careers
* Suppliers
* Contact Us
COMMON HEADER MENU
* IMPORTANT NOTICE
* WORLDWIDE
* GLOBAL
* 日本
Important Notice
This website contains information about products that may not be available in
all countries, or may be available under different trademarks, for different
indications, or in different dosages. Nothing contained herein should be
considered a solicitation, promotion or advertisement for any drug including the
ones under development on this web site.
Any information on the products contained herein is not intended to provide
medical advice nor should be used as a substitute for the advice provided by
your physician or other healthcare provider.
OK
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.
FINANCIAL RESULTS FOR Q2 YTD/FY2024
We announced our financial results for Q2 YTD/FY2024 on October 30th.
Presentation material, video, and meeting script are available.
View more
EVERY DAY OF VISION LOSS IS ONE TOO MANY
Astellas' commitment to helping patients with vision loss and improving
treatment options for eye diseases.
Read more
INTEGRATED REPORT 2024
Please check the latest Integrated Report.
Read more
FROM THE CEO
I will make every effort to navigate Astellas with speed and a sense of urgency
that “our patients are waiting.”
Read more
Latest News
Oct 30, 2024Press Releases
Notice Regarding Foreign Exchange Loss
Oct 30, 2024IR
Posted Financial Results for Q2 YTD/FY2024
Oct 28, 2024Press Releases
Astellas Provides Update on Marketing Authorization Application for Avacincaptad
Pegol (ACP) in the European Union
EXPLORE ALL NEWS
ABOUT US
Astellas aims to stand on the forefront of healthcare change to turn innovative
science into VALUE for patients.
Read more
R & D STRATEGY
Astellas’ Focus Area approach supports our commitment to continuous innovation
and the creation of innovative therapies that directly address the underlying
causes of disease.
Read more
SUSTAINABILITY
We are developing a sustainable society by leveraging Astellas’ strengths and
capabilities.
Read more
PARTNERING WITH ASTELLAS
We are actively seeking collaboration opportunities with external partners.
Read More
Careers
INVESTOR RELATIONS
Read More
ASTELLAS PHARMA’S OFFICIAL LINKEDIN
We share the latest information and topics.
Follow us
MODERN SLAVERY ACT 2015
CONTACT FOR POTENTIAL ACQUISITION OF ASTELLAS’ R＆D PROGRAMS.
Follow us on social media
* Global LinkedIn Community Guidelines
BOTTOM FOOTER MENU
* SITE MAP
* PRIVACY NOTICE
* COOKIES POLICY
* ACCESSIBILITY
* TERMS OF USE
* CONTACT US
* DISASTER INFORMATION FOR EMPLOYEES
© Astellas Pharma Inc.
Update cookie preferences
We use strictly necessary cookies to make our site work and those cannot be
deactivated. We would also like to set additional optional cookies and/or
similar technology and process your personal information which will help us
understand how our website is being used; allow us to enable additional
functionalities aimed to enhance your user experience; personalize our content
to you, including content published and/or promoted through third-party websites
or social media; and track the performance of our ad campaigns. However, we will
not set optional cookies and process your personal information for said purposes
unless you consent to all or some of them. Using this tool will set a cookie on
your device to remember your preferences. For more detailed information about
the type of cookies we use, click the selection link in this banner to find our
Cookies Preference Center. For further information on how we use cookies, please
refer to our Cookies Policy.For more detailed information about the cookies we
use, see our Cookies Policy.
Allow Selection for Optional Cookies Reject All Optional Cookies Allow All
Optional Cookies
YOUR PRIVACY
* YOUR PRIVACY
* STRICTLY NECESSARY COOKIES
* FUNCTIONAL COOKIES
* TARGETING COOKIES & OTHER SIMILAR TECHNOLOGY
* PERFORMANCE COOKIES
YOUR PRIVACY
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of optional cookies. Click on
the different category headings to find out more and change our default
settings. However, blocking some types of cookies may impact your experience of
the site and the services we are able to offer.
More information
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
Cookies Details
FUNCTIONAL COOKIES
Functional Cookies Inactive
These cookies enable the website to provide enhanced functionality and
personalization. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
Cookies Details
TARGETING COOKIES & OTHER SIMILAR TECHNOLOGY
Targeting Cookies & Other similar technology Inactive
These cookies and other similar technology such as pixels may be set through our
site by our advertising partners. They may be used by those companies to build a
profile of your interests and show you relevant or personalized adverts on other
sites. They do not store directly personal information, but are based on
uniquely identifying your browser and internet device. If you do not allow these
cookies, you will experience less targeted advertising. We also use cookies and
pixels to track the performance of our ad campaigns.
Cookies Details
PERFORMANCE COOKIES
Performance Cookies Inactive
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
Cookies Details
Back Button
COOKIE LIST
Filter Button
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Clear
checkbox label label
Apply Cancel
Confirm My Choices
Reject All Allow All